Trademark: 98040905
Word
GOLMEKLI
Status Date
Tuesday, September 17, 2024
Filing Date
Tuesday, June 13, 2023
Published for Opposition
Tuesday, July 23, 2024
5 Pharmaceutical preparations for human use for the treatment of tumors, cancer, and rare diseases; Pharmaceutical preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Pharmaceutical preparations for human use for the treatment of neurofibromatosis; Small molecule therapeutic preparations for human use for the treatment of tumors, cancer, and rare diseases; Small molecule therapeutic preparations for human use for the treatment of diseases in the oncological and neuro-oncological fields; Small molecule therapeutic preparations for human use for the treatment of neurofibromatosis
Jun 16, 2023
New Application Entered
Jul 18, 2023
New Application Office Supplied Data Entered
Feb 5, 2024
Letter Of Protest Evidence Forwarded
Mar 2, 2024
Assigned To Examiner
Mar 9, 2024
Letter Of Protest Evidence Reviewed - Action Taken
Mar 9, 2024
Non-Final Action Written
Mar 9, 2024
Non-Final Action E-Mailed
Mar 9, 2024
Notification Of Non-Final Action E-Mailed
Jun 10, 2024
Application Extension To Response Period - Received
Jun 10, 2024
Application Extension Granted/Receipt Provided
Jun 17, 2024
Approved For Pub - Principal Register
Jun 17, 2024
Examiner's Amendment Entered
Jun 17, 2024
Examiners Amendment -Written
Jul 3, 2024
Notification Of Notice Of Publication E-Mailed
Jun 17, 2024
Notification Of Examiners Amendment E-Mailed
Jun 17, 2024
Examiners Amendment E-Mailed
Jul 11, 2024
Teas Petition To Director Received
Jul 23, 2024
Published For Opposition
Sep 4, 2024
Assigned To Petition Staff
Sep 17, 2024
Noa E-Mailed - Sou Required From Applicant
Jul 23, 2024
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2024
Petition To Director Dismissed
Trademark Alertz updated from USPTO on 2030-01-24
